IP Australia Calls For End To Incremental Drug Patent Extensions
This article was originally published in PharmAsia News
Executive Summary
An Australia government report has recommended changes in the nation's patent laws to tighten the granting of extensions for incremental innovations such as the one recently denied Novartis in India.